The key aim was to discover suitable analytical targets by analyzing human hepatocyte incubation samples with higher-resolution mass spectrometry (HRMS) and to confirm the effects in authentic urine specimens and to find out AB-FUBINACA's metabolic balance in human liver microsomes and compared hepatocyte and urine results with in silico prediction